<SEC-DOCUMENT>0001193125-26-281196-index.html : 20260624
<SEC-HEADER>0001193125-26-281196.hdr.sgml : 20260624
<ACCEPTANCE-DATETIME>20260624164644
ACCESSION NUMBER:		0001193125-26-281196
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20260624
FILED AS OF DATE:		20260624
DATE AS OF CHANGE:		20260624

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Virax Biolabs Group Ltd
		CENTRAL INDEX KEY:			0001885827
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41440
		FILM NUMBER:		261116517

	BUSINESS ADDRESS:	
		STREET 1:		BIOCITY GLASGOW
		STREET 2:		BO'NESS ROAD, NEWHOUSE
		CITY:			LANARKSHIRE
		STATE:			X0
		ZIP:			ML1 5UH
		BUSINESS PHONE:		44 020 7788 7414

	MAIL ADDRESS:	
		STREET 1:		BIOCITY GLASGOW
		STREET 2:		BO'NESS ROAD, NEWHOUSE
		CITY:			LANARKSHIRE
		STATE:			X0
		ZIP:			ML1 5UH

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Virax Biolabs (Cayman) Ltd
		DATE OF NAME CHANGE:	20210930
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>6-k_reverse_split_2026.htm
<DESCRIPTION>6-K
<TEXT>
Document 1 - file: 6-k_reverse_split_2026.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>vrax-ex99_1.htm
<DESCRIPTION>EX-99.1
<TEXT>
Document 2 - file: vrax-ex99_1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>img90071954_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 3 - file: img90071954_0.jpg

</DOCUMENT>
</SEC-DOCUMENT>